Detalhe da pesquisa
1.
Clinical Epidemiology and Risk Factors for Critical Outcomes Among Vaccinated and Unvaccinated Adults Hospitalized With COVID-19-VISION Network, 10 States, June 2021-March 2023.
Clin Infect Dis
; 78(2): 338-348, 2024 02 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37633258
2.
Cumulative cancer locations on prostate biopsy and active surveillance outcomes in the MRI era.
Prostate
; 84(8): 723-730, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38476030
3.
Protection From COVID-19 mRNA Vaccination and Prior SARS-CoV-2 Infection Against COVID-19-Associated Encounters in Adults During Delta and Omicron Predominance.
J Infect Dis
; 227(12): 1348-1363, 2023 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36806690
4.
Protection of Two and Three mRNA Vaccine Doses Against Severe Outcomes Among Adults Hospitalized With COVID-19-VISION Network, August 2021 to March 2022.
J Infect Dis
; 227(8): 961-969, 2023 04 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36415904
5.
Positive surgical margins after breast-conserving surgery for ductal carcinoma in-situ: does histologic grade or estrogen receptor status matter?
Breast Cancer Res Treat
; 199(2): 215-220, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37027122
6.
Clinical Significance of Perineural Invasion in Men With Grade Group 1 Prostate Cancer on Active Surveillance.
J Urol
; 209(1): 180-186, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36073925
7.
Identifying Men Who Can Remain on Active Surveillance Despite Biopsy Reclassification to Grade Group 2 Prostate Cancer.
J Urol
; 210(1): 99-107, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37042826
8.
Effectiveness of Homologous and Heterologous COVID-19 Booster Doses Following 1 Ad.26.COV2.S (Janssen [Johnson & Johnson]) Vaccine Dose Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults - VISION Network, 10 States, December 2021-March 2022.
MMWR Morb Mortal Wkly Rep
; 71(13): 495-502, 2022 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35358170
9.
Effectiveness of COVID-19 mRNA Vaccines Against COVID-19-Associated Hospitalizations Among Immunocompromised Adults During SARS-CoV-2 Omicron Predominance - VISION Network, 10 States, December 2021-August 2022.
MMWR Morb Mortal Wkly Rep
; 71(42): 1335-1342, 2022 Oct 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36264840
10.
Association of prostate cancer polygenic risk score with number and laterality of tumor cores in active surveillance patients.
Prostate
; 81(10): 703-709, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33956350
11.
Transperineal Prostate Biopsy Improves the Detection of Clinically Significant Prostate Cancer among Men on Active Surveillance.
J Urol
; 205(4): 1069-1074, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33487007
12.
Prostate Health Index and multiparametric magnetic resonance imaging to predict prostate cancer grade reclassification in active surveillance.
BJU Int
; 126(3): 373-378, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32367635
13.
Utility of multiparametric magnetic resonance imaging in the risk stratification of men with Grade Group 1 prostate cancer on active surveillance.
BJU Int
; 125(6): 861-866, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32039537
14.
Older Age Predicts Biopsy and Radical Prostatectomy Grade Reclassification to Aggressive Prostate Cancer in Men on Active Surveillance.
J Urol
; 201(1): 98-104, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30114397
15.
Evaluating the impact of length of time from diagnosis to surgery in patients with unfavourable intermediate-risk to very-high-risk clinically localised prostate cancer.
BJU Int
; 124(2): 268-274, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30570825
16.
A comprehensive evaluation of CHEK2 germline mutations in men with prostate cancer.
Prostate
; 78(8): 607-615, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29520813
17.
Optimizing active surveillance strategies to balance the competing goals of early detection of grade progression and minimizing harm from biopsies.
Cancer
; 124(4): 698-705, 2018 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29131319
18.
Tumor Volume on Biopsy of Low Risk Prostate Cancer Managed with Active Surveillance.
J Urol
; 199(4): 954-960, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29074222
19.
Comparison of Biochemical Recurrence-Free Survival after Radical Prostatectomy Triggered by Grade Reclassification during Active Surveillance and in Men Newly Diagnosed with Similar Grade Disease.
J Urol
; 198(3): 608-613, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28347771
20.
Risk prediction tool for grade re-classification in men with favourable-risk prostate cancer on active surveillance.
BJU Int
; 120(1): 25-31, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27469419